GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Net Current Asset Value

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Net Current Asset Value : ₹17.29 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Vaidyane Ayurved Laboratories's net current asset value per share for the quarter that ended in Mar. 2024 was ₹17.29.

The historical rank and industry rank for Vaidyane Ayurved Laboratories's Net Current Asset Value or its related term are showing as below:

NSE:MADHAVBAUG' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 8.72   Med: 17.97   Max: 18.5
Current: 8.94

During the past 6 years, the highest Price-to-Net-Current-Asset-Value Ratio of Vaidyane Ayurved Laboratories was 18.50. The lowest was 8.72. And the median was 17.97.

NSE:MADHAVBAUG's Price-to-Net-Current-Asset-Value is ranked worse than
65.33% of 600 companies
in the Drug Manufacturers industry
Industry Median: 5.61 vs NSE:MADHAVBAUG: 8.94

Vaidyane Ayurved Laboratories Net Current Asset Value Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Net Current Asset Value Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Current Asset Value
Get a 7-Day Free Trial -11.78 -8.42 10.85 12.70 17.29

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only 10.85 - 12.70 16.22 17.29

Competitive Comparison of Vaidyane Ayurved Laboratories's Net Current Asset Value

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaidyane Ayurved Laboratories's Price-to-Net-Current-Asset-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's Price-to-Net-Current-Asset-Value falls into.


;
;

Vaidyane Ayurved Laboratories Net Current Asset Value Calculation

Vaidyane Ayurved Laboratories's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Mar. 2024 is calculated as

Net Current Asset Value Per Share(A: Mar. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(334.663-152.887-0.011-0)/10.513
=17.29

Vaidyane Ayurved Laboratories's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2024 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(334.663-152.887-0.011-0)/10.513
=17.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vaidyane Ayurved Laboratories  (NSE:MADHAVBAUG) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Vaidyane Ayurved Laboratories Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaidyane Ayurved Laboratories Business Description

Traded in Other Exchanges
N/A
Address
201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines